---
figid: PMC5095004__oncotarget-07-36338-g009
figlink: /pmc/articles/PMC5095004/figure/F9/
number: F9
caption: MIR126 targets the expression of IRS1 resulting in the insulin signaling
  pathway disruption. This contributes to lower glucose uptake. Upon energy depletion,
  the AMPK pathway is activated and induces lysosomal autophagy. Inhibition of ACL
  by MIR126 contributes to citrate accumulation in cytosol, inducing HIF1α activation
  and stabilization, leading to GLUT-4 upregulation. MIR126 induces PDK down-regulation,
  which in conjunction with ACL inhibition paradoxically inhibits PDH, possibly due
  to the high level of NADH and citrate/pyruvate in mitochondrial matrix. The associated
  HIF1α stabilization results in lipid droplets accumulation (LD) via increased ‘glyceroneogenesis’
  []. This complex metabolic program leads to the loss of malignancy in MM. The activated
  pathways are shown in red. OAA, oxaloacetic acid; Mal, malic acid; PEP, phosphoenolpyruvate.
pmcid: PMC5095004
papertitle: MicroRNA-126 induces autophagy by altering cell metabolism in malignant
  mesothelioma.
reftext: Marco Tomasetti, et al. Oncotarget. 2016 Jun 14;7(24):36338-36352.
pmc_ranked_result_index: '33393'
pathway_score: 0.9562289
filename: oncotarget-07-36338-g009.jpg
figtitle: MicroRNA-126 induces autophagy by altering cell metabolism in malignant
  mesothelioma
year: '2016'
organisms: Homo sapiens
ndex: bf47a163-dede-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5095004__oncotarget-07-36338-g009.html
  '@type': Dataset
  description: MIR126 targets the expression of IRS1 resulting in the insulin signaling
    pathway disruption. This contributes to lower glucose uptake. Upon energy depletion,
    the AMPK pathway is activated and induces lysosomal autophagy. Inhibition of ACL
    by MIR126 contributes to citrate accumulation in cytosol, inducing HIF1α activation
    and stabilization, leading to GLUT-4 upregulation. MIR126 induces PDK down-regulation,
    which in conjunction with ACL inhibition paradoxically inhibits PDH, possibly
    due to the high level of NADH and citrate/pyruvate in mitochondrial matrix. The
    associated HIF1α stabilization results in lipid droplets accumulation (LD) via
    increased ‘glyceroneogenesis’ []. This complex metabolic program leads to the
    loss of malignancy in MM. The activated pathways are shown in red. OAA, oxaloacetic
    acid; Mal, malic acid; PEP, phosphoenolpyruvate.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAG1
  - ACLY
  - PRKAA2
  - PRKAG2
  - MTOR
  - PDHA2
  - PRKAB2
  - DLD
  - PDHA1
  - SLC2A4
  - PDHB
  - DLAT
  - MAL
  - ULK1
  - PDK4
  - IRS1
  - PAEP
  - PRKAG3
  - FAS
  - PDK2
  - RPTOR
  - PDHX
  - PDK1
  - PRKAA1
  - PRKAB1
  - PDK3
  - Glucose
  - Glycerol-3-P
  - Pyruvate
genes:
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: ACL
  symbol: ACL
  source: hgnc_alias_symbol
  hgnc_symbol: ACLY
  entrez: '47'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: (MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA2
  entrez: '5161'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLD
  entrez: '1738'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHA1
  entrez: '5160'
- word: GLUT-4
  symbol: GLUT4
  source: hgnc_prev_symbol
  hgnc_symbol: SLC2A4
  entrez: '6517'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHB
  entrez: '5162'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: DLAT
  entrez: '1737'
- word: Mal
  symbol: MAL
  source: hgnc_symbol
  hgnc_symbol: MAL
  entrez: '4118'
- word: Ulk1
  symbol: ULK1
  source: hgnc_symbol
  hgnc_symbol: ULK1
  entrez: '8408'
- word: (PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK4
  entrez: '5166'
- word: H(IRS1
  symbol: HIRS-1
  source: hgnc_alias_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: PEP
  symbol: PEP
  source: hgnc_alias_symbol
  hgnc_symbol: PAEP
  entrez: '5047'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: FAs
  symbol: FAS
  source: hgnc_symbol
  hgnc_symbol: FAS
  entrez: '355'
- word: (PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK2
  entrez: '5164'
- word: Raptor
  symbol: raptor
  source: hgnc_alias_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: PDH
  symbol: PDH
  source: bioentities_symbol
  hgnc_symbol: PDHX
  entrez: '8050'
- word: (PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: (PDK
  symbol: PDK
  source: bioentities_symbol
  hgnc_symbol: PDK3
  entrez: '5165'
chemicals:
- word: Glucose
  source: MESH
  identifier: D005947
- word: Glycerol-3-P
  source: MESH
  identifier: D005990
- word: Pyruvate
  source: MESH
  identifier: D011773
diseases: []
figid_alias: PMC5095004__F9
redirect_from: /figures/PMC5095004__F9
figtype: Figure
---
